EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieÄquivalenzstudieOpen Access · CC BY-NC 4.0

Cost‐effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial

Hugo W Schuil iD, Nora Hendriks iD, Mohamed El Alili, Judith E Bosmans, Ruben G Duijnhoven, Bart C H Oskam, Tom J H Arends, Diederick Duijvesz, Alexander D Horsch, Bart van der Heij, Irene Tjiam, Hans van Overhage und 16 weitere

BJU International · 2026-05 · 137 (5) · 906-913

DOI: 10.1111/bju.70218 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 13.03.2026. Verfasst von Hugo W Schuil und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Alrijne Ziekenhuis, Leiderdorp, the Netherlands. Hauptthemen laut MEDLINE: Nephrostomy, Percutaneous, Stents, Ureteral Obstruction, Urolithiasis. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Leading the Change.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate whether percutaneous nephrostomy (PCN) is cost‐effective compared to JJ ureteric stent in the acute treatment of obstructive urolithiasis. Patients and Methods A randomised controlled non‐inferiority trial with 204 patients with obstructive urolithiasis requiring decompression. Participants were randomly assigned to either PCN or JJ stent, with follow‐up until the stone was surgically removed or passed spontaneously. Effectiveness outcomes included time to recovery and quality‐adjusted life years (QALYs). Costs were assessed from a societal perspective, incorporating healthcare, patient‐related, and lost productivity costs.

Results

Weighted mean procedure costs were €685 for PCN and €792 for JJ. Mean total societal costs were €8468 for PCN and €7122 for JJ. Largest cost differences were in productivity loss and home care. Time to recovery and QALYs were similar between groups. The probability that JJ was cost‐effective compared to PCN was 0.74 for quicker recovery time and 0.74 for QALYs at a willingness‐to‐pay threshold of €0. Some cost and quality‐of‐life data were self‐reported, and the analysis reflects the Dutch healthcare system, which may limit generalisability.

Conclusion

The JJ ureteric stent was found to be the likely cost‐effective option compared to PCN, despite higher procedural costs. Procedural costs can be lowered by performing procedures outside of an operating theatre. Most societal costs were made during the waiting period for definitive stone removal; future research should investigate whether total cost can be lowered by reducing waiting times.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrostomy, PercutaneousStentsUreteral ObstructionUrolithiasisHumansCost-Benefit AnalysisCost-Effectiveness AnalysisFemaleMaleMiddle AgedAgedQuality-Adjusted Life YearsTreatment OutcomeAdult

Stichwörter der Autor:innen

Cost‐effectivenessJJ ureteric stentpercutaneous nephrostomyrandomised controlled trialurolithiasis

Autor:innen und Institutionen

  • Department of Urology, Alrijne Ziekenhuis, Leiderdorp, the Netherlands.
  • Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Health Sciences, Vrije Universiteit Amsterdam, Faculty of Science, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
  • Zorginstituut Nederland, Diemen, the Netherlands.
  • Clinical trials unit Healthcare Evaluation and Research, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Urology, Meander Medisch Centrum, Amersfoort, the Netherlands.

ORCID-Profile: Hugo W Schuil, Nora Hendriks, Janneke I M van Uhm, Saskia Weltings

Förderung

  • Leading the Change

Zitieren

APA

Schuil, H. W., Hendriks, N., El Alili, M., Bosmans, J. E., Duijnhoven, R. G., Oskam, B. C. H., Arends, T. J. H., Duijvesz, D., Horsch, A. D., van der Heij, B., Tjiam, I., van Overhage, H., Lamers, A. B. G. N., van Delden, O. M., Scheepens, W., Drossaerts, J. M. A., d'Ancona, F. C. H., Boering, S., van Uhm, J. I. M., …, & Schout, B. M. A. (2026). Cost‐effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial. BJU International, 137(5), 906-913. https://doi.org/10.1111/bju.70218

Vancouver

Schuil HW, Hendriks N, El Alili M, Bosmans JE, Duijnhoven RG, Oskam BCH, et al. Cost‐effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial. BJU International. 2026;137(5):906-913. doi:10.1111/bju.70218

BibTeX
@article{Schuil2026,
  author = {Schuil, Hugo W and Hendriks, Nora and El Alili, Mohamed and Bosmans, Judith E and Duijnhoven, Ruben G and Oskam, Bart C H and Arends, Tom J H and Duijvesz, Diederick and Horsch, Alexander D and van der Heij, Bart and Tjiam, Irene and van Overhage, Hans and Lamers, Armand B G N and van Delden, Otto M and Scheepens, Wout and Drossaerts, Jamie M A and d'Ancona, Frank C H and Boering, Steven and van Uhm, Janneke I M and van der Meer, Rutger W and van Roijen, Herman J H and de Kiefte, Martin and Hendrix, Ad J M and Weltings, Saskia and Pelger, Rob C M and Beerlage, Harrie P and Kamphuis, Guido M and Schout, Barbara M A},
  title = {Cost‐effectiveness of percutaneous nephrostomy vs JJ stent in obstructive urolithiasis: economic evaluation alongside the STent Or NEphrostomy (STONE) randomised controlled trial},
  journal = {BJU International},
  year = {2026},
  volume = {137},
  number = {5},
  pages = {906--913},
  doi = {10.1111/bju.70218}
}
Kostenlos starten →